Located in Israel’s Galilee region, MIGAL is an applied research institute, specializing in biotechnology and computational sciences, plant science, precision agriculture and environmental sciences, as well as food, nutrition and health.
MIGAL scientists wanted to fast-track development of a vaccine for COVID-19 based on their existing virus research.
We realized we needed a flexible system in order to respond to the rapid changes of the viruses, specifically for the SARS-CoV-2.
The institute uses BIOVIA to scale up their research and study mutations of the SARS-CoV-2 virus.
With BIOVIA, MIGAL scientists can streamline their research and accelerate actionable scientific insights.